LUP Statistics
Record
- Title
- Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
- Type
- Journal Article
- Publ. year
- 2006
- Author/s
- Dorkhan, M; Magnusson, Martin; Frid, A; Grubb, A et al.
- Department/s
- Translational Muscle Research; Cardiovascular Research - Hypertension; Department of Clinical Sciences, Malmö; Division of Clinical Chemistry and Pharmacology; Stem Cell Center
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 365 | 9 | 0 |
United States of America  |
134 (37%) |
Germany  |
60 (16%) |
Japan  |
42 (12%) |
China  |
29 (8%) |
India  |
16 (4%) |
United Kingdom of Great Britain and Northern Ireland  |
9 (2%) |
France  |
8 (2%) |
Sweden  |
7 (2%) |
Russian Federation  |
6 (2%) |
Hong Kong (China)  |
6 (2%) |
Australia  |
4 (1%) |
Philippines  |
3 (1%) |
Indonesia  |
3 (1%) |
Pakistan  |
3 (1%) |
Malaysia  |
2 (1%) |
Turkiye  |
2 (1%) |
Ireland  |
2 (1%) |
Ukraine  |
2 (1%) |
Poland  |
2 (1%) |
Denmark  |
2 (1%) |
Canada  |
2 (1%) |
South Africa  |
2 (1%) |
Belgium  |
2 (1%) |
Finland  |
1 (0%) |
Kuwait  |
1 (0%) |
European Union location  |
1 (0%) |
Latvia  |
1 (0%) |
New Zealand  |
1 (0%) |
Peru  |
1 (0%) |
Myanmar  |
1 (0%) |
Hungary  |
1 (0%) |
Afghanistan  |
1 (0%) |
Switzerland  |
1 (0%) |
Libya  |
1 (0%) |
Tunisia  |
1 (0%) |
Netherlands (Kingdom of the)  |
1 (0%) |
Thailand  |
1 (0%) |
Egypt  |
1 (0%) |
Estonia  |
1 (0%) |
Yemen  |
1 (0%) |